Please use this identifier to cite or link to this item:
Regulations on Clinical Trial Recruitment and Advertising
human subject;recruitment;advertising;new drug;clinical trial
|Issue Date:||2021-05-20 14:51:04 (UTC+8)|
In order to protect potential participants, regulations on clinical trial recruitment advertising are necessary. For examples, no claims should be made that the investigational drug is safe or effective, or that it is equivalent or superior to existing treatments. The content of advertising should be pre-reviewed by an IRB, in determining whether it is misleading or too promissory. The advertising should not promote “free medical treatment” or emphasize the trial is paid. When preparing to advertise clinical trials, failing to keep in mind these regulations and relevant guidelines may cause serious consequences to the research.
|Relation:||月旦醫事法報告, No.48, pp.107-113|
|Appears in Collections:||[法律科際整合研究所] 期刊論文|
Files in This Item:
All items in 學術集成 are protected by copyright, with all rights reserved.